Log in to save to my catalogue

Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability...

Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4649399

Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability to express PD-L1 upon interferon exposure

About this item

Full title

Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability to express PD-L1 upon interferon exposure

Publisher

London: BioMed Central Ltd

Journal title

Journal for immunotherapy of cancer, 2015-11, Vol.3 (S2), p.P311-P311, Article P311

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

IntroductionPD-L1-negative tumors assessed by immunohistochemistry often still respond to PD-1 blockade. PD-L1 is inducible by interferon, therefore, absolute negative tumors are the ones unable to up-regulate PD-L1 in response to interferons. Genetic mutations in the interferon receptor signaling pathway leading to loss of PD-L1 up-regulation were...

Alternative Titles

Full title

Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability to express PD-L1 upon interferon exposure

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4649399

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4649399

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1186/2051-1426-3-S2-P311

How to access this item